Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 351

1.

Out With the Old and in With the New: Not So Fast in Hypertrophic Cardiomyopathy.

Maron MS.

JACC Basic Transl Sci. 2019 Nov 25;4(7):814-816. doi: 10.1016/j.jacbts.2019.10.002. eCollection 2019 Nov. No abstract available.

2.

Concerns About the HCM Risk-Kids Study.

Maron BJ, Rowin EJ, Maron MS.

JAMA Cardiol. 2020 Jan 29. doi: 10.1001/jamacardio.2019.5786. [Epub ahead of print] No abstract available.

PMID:
31995123
3.

Multidisciplinary evaluation and management of obstructive hypertrophic cardiomyopathy in 2020: Towards the HCM Heart Team.

Pelliccia F, Alfieri O, Calabrò P, Cecchi F, Ferrazzi P, Gragnano F, Kaski JP, Limongelli G, Maron M, Rapezzi C, Seggewiss H, Yacoub MH, Olivotto I.

Int J Cardiol. 2020 Jan 11. pii: S0167-5273(20)30095-4. doi: 10.1016/j.ijcard.2020.01.021. [Epub ahead of print]

PMID:
31983465
4.

Editorial commentary: Hold your horses (and mice, rats, and cats): How relevant really are animal models of hypertrophic cardiomyopathy?

Maron MS, Rowin EJ, Maron BJ.

Trends Cardiovasc Med. 2019 Dec 18. pii: S1050-1738(19)30165-3. doi: 10.1016/j.tcm.2019.12.002. [Epub ahead of print] No abstract available.

PMID:
31883862
5.

The Hypertrophic Cardiomyopathy Phenotype Viewed Through the Prism of Multimodality Imaging: Clinical and Etiologic Implications.

Rowin EJ, Maron BJ, Maron MS.

JACC Cardiovasc Imaging. 2019 Dec 18. pii: S1936-878X(19)30947-7. doi: 10.1016/j.jcmg.2019.09.020. [Epub ahead of print] Review.

PMID:
31864978
6.

Global no net loss of natural ecosystems.

Maron M, Simmonds JS, Watson JEM, Sonter LJ, Bennun L, Griffiths VF, Quétier F, von Hase A, Edwards S, Rainey H, Bull JW, Savy CE, Victurine R, Kiesecker J, Puydarrieux P, Stevens T, Cozannet N, Jones JPG.

Nat Ecol Evol. 2020 Jan;4(1):46-49. doi: 10.1038/s41559-019-1067-z. Epub 2019 Dec 16.

PMID:
31844192
7.

Intraoperative Provocative Testing in Patients with Obstructive Hypertrophic Cardiomyopathy Undergoing Septal Myectomy.

Bedair Elsayes A, Basura A, Zahedi F, Moreno-Duarte I, Rowin EJ, Maron M, Rastegar H, Cobey FC.

J Am Soc Echocardiogr. 2020 Feb;33(2):182-190. doi: 10.1016/j.echo.2019.08.021. Epub 2019 Nov 15.

PMID:
31740372
8.

Efficacy of Combined Cox-Maze IV and Ventricular Septal Myectomy for Treatment of Atrial Fibrillation in Patients With Obstructive Hypertrophic Cardiomyopathy.

Boll G, Rowin EJ, Maron BJ, Wang W, Rastegar H, Maron MS.

Am J Cardiol. 2020 Jan 1;125(1):120-126. doi: 10.1016/j.amjcard.2019.09.029. Epub 2019 Oct 11.

PMID:
31727261
9.

Three-dimensional Deep Convolutional Neural Networks for Automated Myocardial Scar Quantification in Hypertrophic Cardiomyopathy: A Multicenter Multivendor Study.

Fahmy AS, Neisius U, Chan RH, Rowin EJ, Manning WJ, Maron MS, Nezafat R.

Radiology. 2020 Jan;294(1):52-60. doi: 10.1148/radiol.2019190737. Epub 2019 Nov 12.

PMID:
31714190
10.

The ESC Risk Score Is Less Reliable than ACC/AHA Risk Factors in Hypertrophic Cardiomyopathy: When Sensitivity Trumps Specificity.

Maron MS, Rowin EJ, Maron BJ.

Can J Cardiol. 2019 Dec;35(12):1626-1628. doi: 10.1016/j.cjca.2019.06.018. Epub 2019 Jun 24. No abstract available.

PMID:
31703825
11.

Distinct Subgroups in Hypertrophic Cardiomyopathy in the NHLBI HCM Registry.

Neubauer S, Kolm P, Ho CY, Kwong RY, Desai MY, Dolman SF, Appelbaum E, Desvigne-Nickens P, DiMarco JP, Friedrich MG, Geller N, Harper AR, Jarolim P, Jerosch-Herold M, Kim DY, Maron MS, Schulz-Menger J, Piechnik SK, Thomson K, Zhang C, Watkins H, Weintraub WS, Kramer CM; HCMR Investigators.

J Am Coll Cardiol. 2019 Nov 12;74(19):2333-2345. doi: 10.1016/j.jacc.2019.08.1057.

PMID:
31699273
12.

Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy.

Ghiselli L, Marchi A, Fumagalli C, Maurizi N, Oddo A, Pieri F, Girolami F, Rowin E, Mazzarotto F, Cicoira M, Ribichini F, Arretini A, Targetti M, Passantino S, Cecchi F, Marchionni N, Maron M, Mori F, Olivotto I.

Eur J Prev Cardiol. 2019 Nov 7:2047487319886961. doi: 10.1177/2047487319886961. [Epub ahead of print]

PMID:
31698967
13.

Coexistence of acute takotsubo syndrome and acute coronary syndrome.

Sharkey SW, Kalra A, Henry TD, Smith TD, Pink VR, Lesser JR, Garberich RF, Maron MS, Maron BJ.

Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28595. [Epub ahead of print]

PMID:
31696663
14.

Net positive outcomes for nature.

Bull JW, Milner-Gulland EJ, Addison PFE, Arlidge WNS, Baker J, Brooks TM, Burgass MJ, Hinsley A, Maron M, Robinson JG, Sekhran N, Sinclair SP, Stuart SN, Zu Ermgassen SOSE, Watson JEM.

Nat Ecol Evol. 2020 Jan;4(1):4-7. doi: 10.1038/s41559-019-1022-z. No abstract available.

PMID:
31686021
15.

Impact of Sex on Clinical Course and Survival in the Contemporary Treatment Era for Hypertrophic Cardiomyopathy.

Rowin EJ, Maron MS, Wells S, Patel PP, Koethe BC, Maron BJ.

J Am Heart Assoc. 2019 Nov 5;8(21):e012041. doi: 10.1161/JAHA.119.012041. Epub 2019 Oct 30.

16.

The Guidant Affair revisited…but this time with good news.

Maron BJ, Harris KM, Maron MS.

Heart Rhythm. 2019 Oct 5. pii: S1547-5271(19)30916-6. doi: 10.1016/j.hrthm.2019.10.010. [Epub ahead of print] No abstract available.

PMID:
31593780
17.

Increasing evidence that risk scores underperform in predicting sudden death in hypertrophic cardiomyopathy.

Maron M, Rowin E, Maron BJ.

Heart. 2019 Dec;105(24):1850-1851. doi: 10.1136/heartjnl-2019-315694. Epub 2019 Sep 24. No abstract available.

PMID:
31551293
18.

Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy.

Maron BJ, Rowin EJ, Maron MS.

Circ Res. 2019 Aug 2;125(4):370-378. doi: 10.1161/CIRCRESAHA.119.315159. Epub 2019 Aug 1.

PMID:
31518168
19.

Offsetting impacts of development on biodiversity and ecosystem services.

Sonter LJ, Gordon A, Archibald C, Simmonds JS, Ward M, Metzger JP, Rhodes JR, Maron M.

Ambio. 2020 Apr;49(4):892-902. doi: 10.1007/s13280-019-01245-3. Epub 2019 Sep 10.

PMID:
31506844
20.

Guideline-Based Referral for Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Is Associated With Excellent Clinical Outcomes.

Kimmelstiel C, Zisa DC, Kuttab JS, Wells S, Udelson JE, Wessler BS, Rastegar H, Kapur NK, Weintraub AR, Maron BJ, Maron MS, Rowin EJ.

Circ Cardiovasc Interv. 2019 Jul;12(7):e007673. doi: 10.1161/CIRCINTERVENTIONS.118.007673. Epub 2019 Jul 12.

PMID:
31296080
21.

Enhancing Medical Student-Interpreter Collaboration in an Urban Free Clinic.

Mazori AY, Maron MI, Osterbur ML Badhey, Santos D, Marco VF, Lin J, Cortijo A, Nosal S, Schoenbaum E.

Fam Med. 2019 Jul;51(7):593-597. doi: 10.22454/FamMed.2019.229662.

22.
23.

Structurally Normal Hearts Are Uncommonly Associated With Sudden Deaths in Athletes and Young People.

Thiene G, Rizzo S, Schiavon M, Maron MS, Zorzi A, Corrado D, Maron BJ, Basso C.

J Am Coll Cardiol. 2019 Jun 18;73(23):3031-3032. doi: 10.1016/j.jacc.2019.03.497. No abstract available.

PMID:
31196462
24.

Chronic Heart Failure Is Infrequently Associated With Renal Dysfunction in Hypertrophic Cardiomyopathy.

Rowin EJ, Romashko M, Testani JM, Koethe BC, Saxena D, Udelson JE, Maron BJ, Maron MS.

J Card Fail. 2019 Aug;25(8):690-692. doi: 10.1016/j.cardfail.2019.05.012. Epub 2019 May 31. No abstract available.

PMID:
31158468
25.

Assessing blue wildebeests' vigilance, grouping and foraging responses to perceived predation risk using playback experiments.

Dannock RJ, Pays O, Renaud PC, Maron M, Goldizen AW.

Behav Processes. 2019 Jul;164:252-259. doi: 10.1016/j.beproc.2019.05.021. Epub 2019 May 20.

PMID:
31121214
26.

Establishment of Specialized Clinical Cardiovascular Genetics Programs: Recognizing the Need and Meeting Standards: A Scientific Statement From the American Heart Association.

Ahmad F, McNally EM, Ackerman MJ, Baty LC, Day SM, Kullo IJ, Madueme PC, Maron MS, Martinez MW, Salberg L, Taylor MR, Wilcox JE.

Circ Genom Precis Med. 2019 Jun;12(6):e000054. doi: 10.1161/HCG.0000000000000054. Epub 2019 May 23.

PMID:
31117808
27.

Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.

Maron MS, Rowin EJ, Wessler BS, Mooney PJ, Fatima A, Patel P, Koethe BC, Romashko M, Link MS, Maron BJ.

JAMA Cardiol. 2019 Jul 1;4(7):644-657. doi: 10.1001/jamacardio.2019.1391.

PMID:
31116360
28.

Influenza Antigen Engineering Focuses Immune Responses to a Subdominant but Broadly Protective Viral Epitope.

Bajic G, Maron MJ, Adachi Y, Onodera T, McCarthy KR, McGee CE, Sempowski GD, Takahashi Y, Kelsoe G, Kuraoka M, Schmidt AG.

Cell Host Microbe. 2019 Jun 12;25(6):827-835.e6. doi: 10.1016/j.chom.2019.04.003. Epub 2019 May 16.

PMID:
31104946
29.

Impact of Effective Management Strategies on Patients With the Most Extreme Phenotypic Expression of Hypertrophic Cardiomyopathy.

Rowin EJ, Maron BJ, Romashko M, Wang W, Rastegar H, Link MS, Maron MS.

Am J Cardiol. 2019 Jul 1;124(1):113-121. doi: 10.1016/j.amjcard.2019.04.002. Epub 2019 Apr 9.

PMID:
31027655
30.

Moving Beyond the Sarcomere to Explain Heterogeneity in Hypertrophic Cardiomyopathy: JACC Review Topic of the Week.

Maron BJ, Maron MS, Maron BA, Loscalzo J.

J Am Coll Cardiol. 2019 Apr 23;73(15):1978-1986. doi: 10.1016/j.jacc.2019.01.061. Review.

PMID:
31000001
31.

A composite measure of habitat loss for entire assemblages of species.

Simmonds JS, Watson JEM, Salazar A, Maron M.

Conserv Biol. 2019 Dec;33(6):1438-1447. doi: 10.1111/cobi.13331. Epub 2019 Jun 24.

PMID:
30980558
32.

Program Development of Integrated Psychological Services for Hospitalized Patients with Intravenous Drug Use Histories.

Gill AD, McCuin T, Maron M.

J Clin Psychol Med Settings. 2020 Mar;27(1):22-30. doi: 10.1007/s10880-019-09616-4.

PMID:
30949791
33.

Safety, Side Effects and Relative Efficacy of Medications for Rhythm Control of Atrial Fibrillation in Hypertrophic Cardiomyopathy.

Miller CAS, Maron MS, Estes NAM III,, Price LL, Rowin EJ, Maron BJ, Link MS.

Am J Cardiol. 2019 Jun 1;123(11):1859-1862. doi: 10.1016/j.amjcard.2019.02.051. Epub 2019 Mar 13.

PMID:
30922542
34.

Letter by Maron et al Regarding Article, "Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)".

Maron BJ, Rowin EJ, Maron MS.

Circulation. 2019 Mar 19;139(12):1557-1558. doi: 10.1161/CIRCULATIONAHA.118.038189. No abstract available.

PMID:
30883223
35.

Clinical Course and Significance of Hypertrophic Cardiomyopathy Without Left Ventricular Hypertrophy.

Maurizi N, Michels M, Rowin EJ, Semsarian C, Girolami F, Tomberli B, Cecchi F, Maron MS, Olivotto I, Maron BJ.

Circulation. 2019 Feb 5;139(6):830-833. doi: 10.1161/CIRCULATIONAHA.118.037264. No abstract available.

PMID:
30715937
36.

Benefit of Cardiac Resynchronization Therapy in End-Stage Nonobstructive Hypertrophic Cardiomyopathy.

Rowin EJ, Mohanty S, Madias C, Maron BJ, Maron MS.

JACC Clin Electrophysiol. 2019 Jan;5(1):131-133. doi: 10.1016/j.jacep.2018.08.018. No abstract available.

37.

Myocardial Strain in Hypertrophic Cardiomyopathy: A Force Worth Pursuing?

Maron MS, Wells S.

JACC Cardiovasc Imaging. 2019 Oct;12(10):1943-1945. doi: 10.1016/j.jcmg.2018.09.026. Epub 2019 Jan 16. No abstract available.

PMID:
30660525
38.

Case for Earlier Surgical Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.

Maron MS, Spirito P, Maron BJ.

Circulation. 2018 Nov 6;138(19):2076-2078. doi: 10.1161/CIRCULATIONAHA.118.035484. No abstract available.

PMID:
30474424
39.

Metrics of progress in the understanding and management of threats to Australian birds.

Garnett ST, Butchart SHM, Baker GB, Bayraktarov E, Buchanan KL, Burbidge AA, Chauvenet ALM, Christidis L, Ehmke G, Grace M, Hoccom DG, Legge SM, Leiper I, Lindenmayer DB, Loyn RH, Maron M, McDonald P, Menkhorst P, Possingham HP, Radford J, Reside AE, Watson DM, Watson JEM, Wintle B, Woinarski JCZ, Geyle HM.

Conserv Biol. 2019 Apr;33(2):456-468. doi: 10.1111/cobi.13220. Epub 2018 Nov 22.

PMID:
30465331
40.

Summary of Presentations and Discussions of Hypertrophic Cardiomyopathy at the 2018 Boston International Summit VI Including Consensus, Controversies, and Unmet Needs.

Maron BJ, Maron MS.

Am J Cardiol. 2018 Oct 1;122(7):1281-1286. doi: 10.1016/j.amjcard.2018.06.018. Epub 2018 Jul 4. No abstract available.

PMID:
30173818
41.

Reply: Atrial Fibrillation in Hypertrophic Cardiomyopathy.

Maron MS, Udelson JE, Rowin EJ, Maron BJ.

JACC Heart Fail. 2018 Sep;6(9):807-808. doi: 10.1016/j.jchf.2018.06.009. No abstract available.

42.

Automated Cardiac MR Scar Quantification in Hypertrophic Cardiomyopathy Using Deep Convolutional Neural Networks.

Fahmy AS, Rausch J, Neisius U, Chan RH, Maron MS, Appelbaum E, Menze B, Nezafat R.

JACC Cardiovasc Imaging. 2018 Dec;11(12):1917-1918. doi: 10.1016/j.jcmg.2018.04.030. Epub 2018 Aug 15. No abstract available.

43.

Clinical Spectrum and Management Implications of Left Ventricular Outflow Obstruction With Mild Ventricular Septal Thickness in Hypertrophic Cardiomyopathy.

Rowin EJ, Maron BJ, Chokshi A, Kannappan M, Arkun K, Wang W, Rastegar H, Maron MS.

Am J Cardiol. 2018 Oct 15;122(8):1409-1420. doi: 10.1016/j.amjcard.2018.06.055. Epub 2018 Jul 17.

PMID:
30107902
44.

Bold nature retention targets are essential for the global environment agenda.

Maron M, Simmonds JS, Watson JEM.

Nat Ecol Evol. 2018 Aug;2(8):1194-1195. doi: 10.1038/s41559-018-0595-2. No abstract available.

PMID:
29915340
45.

Left ventricular apical aneurysm in hypertrophic cardiomyopathy as a risk factor for sudden death at any age.

Rowin EJ, Maron BJ, Chokshi A, Maron MS.

Pacing Clin Electrophysiol. 2018 Jun 12. doi: 10.1111/pace.13413. [Epub ahead of print] Review.

PMID:
29893504
46.

Short-term response of a declining woodland bird assemblage to the removal of a despotic competitor.

Davitt G, Maute K, Major RE, McDonald PG, Maron M.

Ecol Evol. 2018 Apr 16;8(10):4771-4780. doi: 10.1002/ece3.4016. eCollection 2018 May.

47.

Response by Rowin et al to Letter Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".

Rowin EJ, Maron MS, Maron BJ.

Circulation. 2018 Jun 5;137(23):2541-2542. doi: 10.1161/CIRCULATIONAHA.118.034857. No abstract available.

PMID:
29866781
48.

J Point Elevation in Hypertrophic Cardiomyopathy: Riding a New Wave in Risk Stratification?

Maron MS.

JACC Clin Electrophysiol. 2017 Oct;3(10):1143-1145. doi: 10.1016/j.jacep.2017.06.004. Epub 2017 Sep 13. No abstract available.

49.

Global Burden of Hypertrophic Cardiomyopathy.

Maron BJ, Rowin EJ, Maron MS.

JACC Heart Fail. 2018 May;6(5):376-378. doi: 10.1016/j.jchf.2018.03.004. Review. No abstract available.

50.

Association Between Race and Clinical Profile of Patients Referred for Hypertrophic Cardiomyopathy.

Wells S, Rowin EJ, Bhatt V, Maron MS, Maron BJ.

Circulation. 2018 May 1;137(18):1973-1975. doi: 10.1161/CIRCULATIONAHA.117.032838. No abstract available.

PMID:
29712699

Supplemental Content

Support Center